Authors: Parra, HS Tixi, L Latteri, F Bretti, S Alloisio, M Gravina, A Lionetto, R Bruzzi, P Dani, C Rosso, R Cosso, M Balzarini, L Santoro, A Ardizzoni, A

Citation: Hs. Parra et al., Combined regimen of cisplatin, doxorubicin, and alpha-2b interferon in thetreatment of advanced malignant pleural mesothelioma - A phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP), CANCER, 92(3), 2001, pp. 650-656

Authors: Santoro, A Bredenfeld, H Devizzi, L Tesch, H Bonfante, V Viviani, S Fielder, F Parra, HS Benoehr, C Pacini, M Bonadonna, G Diehl, V

Citation: A. Santoro et al., Gemcitabine in the treatment of refractory Hodgkins's disease: Results of a multicenter phase II study, J CL ONCOL, 18(13), 2000, pp. 2615-2619

Authors: Bozzetti, F Cozzaglio, L Gavazzi, C Bidoli, P Bonfanti, G Montalto, F Parra, HS Valente, M Zucali, R

Citation: F. Bozzetti et al., Nutritional support in patients with cancer of the esophagus: Impact on nutritional status, patient compliance to therapy, and survival, TUMORI, 84(6), 1998, pp. 681-686